Pharmacokinetics and Hepatic Safety of EGCG
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ayman Al-Hendy, MD,PhD
University of Chicago
Principal Investigator - Esther Eisenberg, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Study Director - Frank Gonzales, MD
University of Illinois at Chicago
Study Director - Heping Zhang, PhD
Yale University
Study Director - Hugh Taylor, MD
Yale University
Study Director - James Segars, MD
Johns Hopkins University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Johns Hopkins Medicine
Baltimore, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Nov 2020
- Primary completion
- 31 Jan 2022
- Completion
- 31 Jan 2022
- Last update posted
- 5 Jun 2023
- Registered enrollment
- 39
- Registry id
- NCT04177693
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.